User profiles for John-Arne Røttingen
 | John-Arne RøttingenVerified email at hks12.harvard.edu Cited by 15546 |
Access to effective antimicrobials: a worldwide challenge
…, P Matsoso, S Pant, C Brower, JA Røttingen… - The Lancet, 2016 - thelancet.com
Recent years have seen substantial improvements in life expectancy and access to
antimicrobials, especially in low-income and lower-middle-income countries, but increasing …
antimicrobials, especially in low-income and lower-middle-income countries, but increasing …
[HTML][HTML] Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster …
…, A Soumah, S Trelle, AS Vicari, JA Røttingen… - The Lancet, 2017 - thelancet.com
Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based
candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
…, CH Watson, S Kéïta, MP Kieny, JA Røttingen - The Lancet, 2015 - thelancet.com
Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine
expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola …
expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola …
A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?
JA Røttingen, DW Cameron… - Sexually transmitted …, 2001 - journals.lww.com
… RØTTINGEN, JOHN-ARNE MD, PhD *†‡ ; WILLIAM CAMERON, D. MD § ; GARNETT,
GEOFFREY P. PhD * … JA Røttingen, a Research Fellow at the University of Oslo, was …
GEOFFREY P. PhD * … JA Røttingen, a Research Fellow at the University of Oslo, was …
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
JA Røttingen, S Regmi, M Eide, AJ Young… - The Lancet, 2013 - thelancet.com
The need to align investments in health research and development (R&D) with public health
demands is one of the most pressing global public health challenges. We aim to provide a …
demands is one of the most pressing global public health challenges. We aim to provide a …
[HTML][HTML] Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
…, JM Robinson, PM Heaton, JA Røttingen - The Lancet Global …, 2018 - thelancet.com
Background The Coalition for Epidemic Preparedness Innovations was established in 2016,
to develop vaccines that can contribute to preparedness for outbreaks of epidemic …
to develop vaccines that can contribute to preparedness for outbreaks of epidemic …
Quasi-experimental study designs series—paper 4: uses and value
Quasi-experimental studies are increasingly used to establish causal relationships in
epidemiology and health systems research. Quasi-experimental studies offer important …
epidemiology and health systems research. Quasi-experimental studies offer important …
Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions?
In recent years, there have been several calls for rigorous health policy and systems research
to inform efforts to strengthen health systems (HS) in low- and middle-income countries (…
to inform efforts to strengthen health systems (HS) in low- and middle-income countries (…
Exploring the evidence base for national and regional policy interventions to combat resistance
…, HB Pedersen, G Permanand, A Zumla, JA Røttingen… - The Lancet, 2016 - thelancet.com
The effectiveness of existing policies to control antimicrobial resistance is not yet fully
understood. A strengthened evidence base is needed to inform effective policy interventions …
understood. A strengthened evidence base is needed to inform effective policy interventions …
Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries
Access to quality-assured antimicrobials is regarded as part of the human right to health, yet
universal access is often undermined in low-income and middle-income countries. Lack of …
universal access is often undermined in low-income and middle-income countries. Lack of …
